Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9139693rdf:typepubmed:Citationlld:pubmed
pubmed-article:9139693lifeskim:mentionsumls-concept:C0014597lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C0003018lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C0021547lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C1752727lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:9139693lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:9139693pubmed:issue19lld:pubmed
pubmed-article:9139693pubmed:dateCreated1997-6-16lld:pubmed
pubmed-article:9139693pubmed:abstractTextChronic stimulation of WB rat liver epithelial cells by angiotensin II (Ang II) resulted in the down-regulation of both type I and type III myo-inositol 1,4,5-trisphosphate receptors (IP3Rs). Stimulation with vasopressin, bradykinin, epidermal growth factor, or 12-O-tetradecanoylphorbol-13-acetate was without effect. Ang II-induced down-regulation of IP3Rs could be detected within 2 h and resulted in an inhibition of IP3-induced Ca2+ release from permeabilized cells. IP3R down-regulation was reversible, and both homo- and heterooligomers of IP3Rs were equally susceptible to Ang II-induced degradation. Chloroquine and NH4Cl increased the basal levels of IP3Rs by 2-fold, suggesting that the basal turnover of IP3Rs occurs via a lysosomal pathway. However, Ang II-induced degradation of IP3R was not affected by these inhibitors, suggesting that stimulated degradation of IP3Rs occurs via a non-lysosomal pathway. The cysteine protease and proteasomal inhibitor N-acetyl-Leu-Leu-norleucinal completely prevented Ang II-mediated down-regulation of IP3Rs, whereas the structural analog N-acetyl-Leu-Leu-methioninal was without effect. Lactacystin, a highly specific proteasome inhibitor, also blocked Ang II-mediated IP3R degradation. Stimulation with Ang II increased the amount of IP3R immunoprecipitated by anti-ubiquitin antibodies. We conclude that Ang II-stimulated IP3R degradation involves enhanced ubiquitination of the protein and degradation by the proteasome pathway.lld:pubmed
pubmed-article:9139693pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:languageenglld:pubmed
pubmed-article:9139693pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:citationSubsetIMlld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139693pubmed:statusMEDLINElld:pubmed
pubmed-article:9139693pubmed:monthMaylld:pubmed
pubmed-article:9139693pubmed:issn0021-9258lld:pubmed
pubmed-article:9139693pubmed:authorpubmed-author:JosephS KSKlld:pubmed
pubmed-article:9139693pubmed:authorpubmed-author:BokkalaSSlld:pubmed
pubmed-article:9139693pubmed:issnTypePrintlld:pubmed
pubmed-article:9139693pubmed:day9lld:pubmed
pubmed-article:9139693pubmed:volume272lld:pubmed
pubmed-article:9139693pubmed:ownerNLMlld:pubmed
pubmed-article:9139693pubmed:authorsCompleteYlld:pubmed
pubmed-article:9139693pubmed:pagination12454-61lld:pubmed
pubmed-article:9139693pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:meshHeadingpubmed-meshheading:9139693-...lld:pubmed
pubmed-article:9139693pubmed:year1997lld:pubmed
pubmed-article:9139693pubmed:articleTitleAngiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway.lld:pubmed
pubmed-article:9139693pubmed:affiliationDepartment of Pathology, Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania 19107, USA.lld:pubmed
pubmed-article:9139693pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9139693pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:25679entrezgene:pubmedpubmed-article:9139693lld:entrezgene
entrez-gene:50522entrezgene:pubmedpubmed-article:9139693lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9139693lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139693lld:pubmed